Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 41Esophageal Squamous Cell Carcinoma 17Carcinoma, Squamous Cell 5Neoplasms 4Adenocarcinoma 4Sarcopenia 2Radiation Injuries 2Obesity 2Anastomotic Leak 2Stomach Neoplasms 1Respiratory Insufficiency 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Pulmonary Fibrosis 1Postoperative Complications 1Pneumonia 1Pathologic Complete Response 1Pain, Postoperative 1Osteoporosis 1Obesity, Abdominal 1Neoplastic Cells, Circulating 1National Cancer Center/Cancer Hospital 1Motor Activity 1Margins of Excision 1Lymphatic Metastasis 1Loco-regional Esophageal Cancer 1Esophageal Diseases 1Deglutition Disorders 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Brain Neoplasms 1

Interventions

Carboplatin 5pembrolizumab 4Trastuzumab 4Oxaliplatin 4Fluorouracil 4Cyclophosphamide 4Radiotherapy 3Paclitaxel 3Endoscopy 3Docetaxel 3Cytarabine 3Chemoradiotherapy 3Capecitabine 3toripalimab 2Tretinoin 2Surgical Procedures, Operative 2Standard of Care 2Observation 2Neoadjuvant Therapy 2Metformin 2Magnetic Resonance Imaging 2Leucovorin 2Irinotecan 2Immunotherapy 2Immune Checkpoint Inhibitors 2Epirubicin 2Drug Therapy 2Doxorubicin 2Cisplatin 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pathologic Complete Response × Esophagectomy × Clear all
NCT04006041 2019-12-26

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Sun Yat-sen University

Phase 2 Unknown
44 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡